ArticleVaccines2022

Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge.

Riccardo Scotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.